ALAS2 TEP: Structural Biology Tools for Haem Biosynthesis Research

Erythroid-specific 5’-Aminolevulinate synthase (ALAS2) catalyzes the first and rate-determining step in haem biosynthesis. This Target Enabling Package from the University of Oxford provides structural biology tools to investigate gain-of-function mutations and explore substrate reduction therapy for porphyria disorders.

Use Cases

• Modeling enzyme over-activity based on mutations in the ALAS2 C-terminus described in the package
• Identifying chemical starting points for metabolic intervention as substrate reduction therapy
• Studying the haem biosynthetic pathway downstream of ALAS2 for porphyria research

Strengths

• Focuses on a specific, rate-determining enzyme (ALAS2) in a critical biological pathway
• Provides tools for two distinct research aspects: mutation analysis and chemical intervention

Limitations

• Row count and dataset scale are unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download

Provenance

Source

University of Oxford